We are live on ! Find out more
BCPEM

Bain Capital Public Equity Management Portfolio holdings

AUM $1.05B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
AUM
$1.48B
AUM Growth
+$108M
Cap. Flow
+$50.4M
Cap. Flow %
3.4%
Top 10 Hldgs %
59.27%
Holding
99
New
32
Increased
13
Reduced
17
Closed
36

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$290M
2
MULE
MuleSoft, Inc.
MULE
+$67.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$28.3M
4
BA icon
Boeing
BA
+$22.6M
5
AZN icon
AstraZeneca
AZN
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 43.27%
2 Consumer Discretionary 12.69%
3 Healthcare 12.46%
4 Industrials 11.24%
5 Communication Services 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
76
Gilead Sciences
GILD
$181B
-55,864
Closed -$4.21M
GSK icon
77
PUT
GSK
GSK
$100B
-5,600
Closed -$140K
HAL icon
78
Halliburton
HAL
$29.7B
-262,937
Closed -$12.3M
IBN icon
79
ICICI Bank
IBN
$102B
-779,461
Closed -$6.9M
IRWD icon
80
Ironwood Pharmaceuticals
IRWD
$671M
-348,232
Closed -$4.5M
MRK icon
81
CALL
Merck
MRK
$355B
-2,934
Closed -$127K
NXPI icon
82
NXP Semiconductors
NXPI
$57.1B
-242,036
Closed -$28.3M
ORLY icon
83
O'Reilly Automotive
ORLY
$68.9B
-789,240
Closed -$13M
PLNT icon
84
Planet Fitness
PLNT
$3.84B
-322,784
Closed -$12.2M
RH icon
85
RH
RH
$2.36B
-82,394
Closed -$7.85M
SYRE icon
86
Spyre Therapeutics
SYRE
$8.02B
-384
Closed -$95K
UAL icon
87
United Airlines
UAL
$34.7B
-109,696
Closed -$7.62M
VRTX icon
88
PUT
Vertex Pharmaceuticals
VRTX
$130B
-600
Closed -$372K
WT icon
89
WisdomTree
WT
$3.35B
-943,244
Closed -$8.65M
KA
90
DELISTED
Kineta, Inc. Common Stock
KA
-2,857
Closed -$1.9M
UMPQ
91
DELISTED
Umpqua Holdings Corp
UMPQ
-517,908
Closed -$11.1M
CTXS
92
CALL
DELISTED
Citrix Systems Inc
CTXS
-1,333
Closed -$413K
ARD
93
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
-48,834
Closed -$912K
ALXN
94
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
-450
Closed -$82K
ETFC
95
DELISTED
E*Trade Financial Corporation
ETFC
-164,381
Closed -$9.11M
AVXS
96
CALL
DELISTED
AveXis, Inc. Common Stock
AVXS
-210
Closed -$158K
AVXS
97
DELISTED
AveXis, Inc. Common Stock
AVXS
-119,506
Closed -$14.8M
MULE
98
DELISTED
MuleSoft, Inc.
MULE
-1,527,689
Closed -$67.2M
SBNY
99
DELISTED
Signature Bank
SBNY
-98,597
Closed -$14M

Similar funds

Bain Capital Public Equity Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bain Capital Public Equity Management held 99 positions worth $1.48B, up 7.9% from $1.37B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Bain Capital Public Equity Management deployed $50.4M of net new capital in Q2 2018, opening 32 new positions and adding to 13 existing holdings. Its largest new stake was DocuSign: 6,491,125 shares worth $344M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Altaba Inc, an estimated $290M trimmed.

  • Bain Capital Public Equity Management's largest Q2 2018 buy was DocuSign: 6,491,125 shares worth $344M.
  • Bain Capital Public Equity Management added most to Vertex Pharmaceuticals in Q2 2018, an estimated $23.4M increase.
  • Bain Capital Public Equity Management's biggest Q2 2018 reduction was Altaba Inc, cutting an estimated $290M.
  • Bain Capital Public Equity Management fully exited MuleSoft, Inc. in Q2 2018, selling an estimated $67.2M.
  • Bain Capital Public Equity Management's ten largest holdings make up 59% of its $1.48B portfolio in Q2 2018.
  • Bain Capital Public Equity Management opened 32 new positions and closed 36 in Q2 2018.
  • Bain Capital Public Equity Management's portfolio value rose 7.9% quarter-over-quarter to $1.48B.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.